Laboratorios Ojer Pharma SL develops dermo-pharmaceutical products. Its pipeline encompasses dermatological products that address the treatment and therapeutic needs of skin diseases. The firm’s therapeutic areas cover infections, dermatitis, and ulceration. It also engages in research and development activities, laboratory testing, patent application, and partnerships with academic institutions and research centers. The company was founded on September 19, 2005 by Carlos Gonzalez Ojer and is headquartered in Pamplona, Spain.

Shengzhan Biotechnology Co., Ltd. was established in April of the Republic of China. It is an emerging important strategic industry. Its business is based on biotechnology, including microbial fermentation technology, research and development and production of APIs, health food ingredients, animal feed additives. And agricultural biotechnology products. The domestic stock listed company Shengda Chemical Pharmaceutical Co., Ltd. is the parent company of the company holding more than 50% of the shares. The company is a subsidiary of Shengda Company which is vertically integrated, aiming at developing high-tech and high value-added products. Reduce costs and benefit more people.

Part of GSK Plc, Beecham Group Plc is a British company located in Middlesex. The firm functions as an investment holding company. It was founded in 1928.\nThe company says this about itself: The principal activity Of the Company is the holding of Intercompany bans and receipt Of interest. The Company had previously been an investment holding company. The Company is a member Of the GlaxoSmithKline Group (the 'Group\"). The directors do not envisage any change to the nature of the business in the future,

Smithkline Beckman Corp, part of GSK Plc, is an American company located in Philadelphia, PA, involved in pharmaceutical preparations. On July 27, 1989 Smithkline Beecham Plc acquired Smithkline Beckman Corp for $16,082.37 million.

Helperby Therapeutics (Helperby) is a biopharmaceutical company dedicated to developing the next generation of lifesaving antibiotics. Existing antibiotic treatments are rapidly becoming obsolete. Doctors increasingly rely on last resort antibiotics such as carbapenems and colistin. As harmful bacteria continue to mutate, this final line of resistance will eventually fail. Helperby’s unique antibiotic technology outsmarts highly resistant bacteria by combining new resistance breakers with old antibiotics to create a whole new generation of therapies. This new lease of life for antibiotics will help to sustain our defence against life threatening superbugs for years to come.

Perrigo Israel Pharmaceuticals Ltd. develops and markets generic products, pharmaceutical ingredients, novel dermatological products, and consumer products. The firm operates manufacturing facilities in the United States, Israel, United Kingdom, Mexico, and Germany. The company was founded in 1983 and is headquartered in Bnei Braq, Israel

Biosynexus, Inc. develops and markets pharmaceutical products. The company is headquartered in Rockville, MD.

Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK.

Glenmark was founded with a vision to emerge as a leading integrated research-based, global pharmaceutical company. Over the decades, we have established ourselves as a leading player in the discovery of new molecules both NCEs (New Chemical Entity) and NBEs (New Biological Entity). They have several molecules in various stages of pre-clinical and clinical development and are primarily focused in the areas of Oncology, Respiratory and Dermatology.

Boulos & Cooper Pharmaceuticals is a proprietary company focused on the development of a new class of antibiotics with novel targets. Being a pioneer in the field, the company wholly owns a strong and expanding IP portfolio with patents granted in AU and the US in addition to a number of other provisional and PCT filings. The pharmaceutical company established a framework with a number of industry partners for the development of its key areas of research, operating leanly, and maximizing investment in research. They are proud of their progress and achievements to date and they remain focussed on the work ahead and believes that innovative and promising technologies are the key to creating true value for their investors. It was incorporated by Dr. Ramiz Boulos in 2013 and is based in Perth, Western Australia.

Stiefel Research Australia Pty Ltd., part of GSK Plc, is an Australian company located in Rowville that develops delivery systems for new dermatology products. Connetics Corp. acquired Stiefel Research Australia Pty Ltd. from FH Faulding & Co. Ltd. on April 23, 2001 for $15.93 million.

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. engages in pharmaceutical research and development, manufacturing and sales, pharmaceutical modern logistics, health industry, and medical manufacturing and sales of beauty product. It offers Chinese patent drug, immunosuppressive agents, endocrine drugs, digestive system drugs, antineoplastic drugs, cardiovascular drugs, antibiotic drugs, medical cosmetology, and scientific research equipment. The company was founded on December 31, 1992 and is headquartered in Hangzhou, China.

Yissum is the technology transfer company of The Hebrew University of Jerusalem. Founded in 1964, it is the 3rd company of its kind ever created, and has a rich tradition of innovation and commercialization. Through our efforts to identify and create breakthrough scientific research at Hebrew University, we aspire to advance commercial solutions to the most pressing global challenges facing humanity. (Contact Tamir Huberman) Some of our well-known spin-off companies include Mobileye, Orcam, Collplant, Qlight, and Briefcam. Yissum’s business partners span the globe and include companies such as Novartis, Johnson & Johnson, Merck, Intel, Google, Boston Scientific, ICL and many more. Since its inception, Yissum has registered 10,000+ patents covering 2,800+ inventions; licensed 900 technologies and produced 130+ spin-off companies.

Part of GSK Plc, Laboratorios Dermatol��gicos Darier SA de CV is a Mexican company located in Mexico City specializing in pharmaceutical preparations. Ricardo Jesus Spinola Sevilla is currently the CEO of the firm.

Zeus Scientific, Inc., part of Sebia SA, is an American company located in Branchburg, NJ, that manufactures and develops in-vitro diagnostic immunoassays devices. The firm was founded by John Tourville and Scott Tourville. Scott Tourville is currently the CEO of the company. On October 11, 2022 Sebia SA acquired Zeus Scientific, Inc.\nThe company says this about itself: For over 45 years, ZEUS Scientific has been developing and manufacturing a wide variety of high-quality, in vitro diagnostic immunoassays for numerous infectious diseases and autoimmune disorders. Based in Branchburg, NJ, USA, ZEUS Scientific markets its products around the world with both a direct domestic sales team and an extensive international distribution network. ZEUS Scientific is a quality-minded, family-owned business that is fully certified and audited to: ISO 13485 (2016), MDSAP (Canada, Australia, USA), FDA QSR (1996: 21 CFR part 820), IVD 98/79/EEC and Health Canada MDR (SOR/98-282).

Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ.